ArticleInternational journal of molecular sciences2022

Characterization of Vemurafenib-Resistant Melanoma Cell Lines Reveals Novel Hallmarks of Targeted Therapy Resistance.

Martina Radić et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.